Urinary Tract Infection (Klebsiella pneumoniae)
Overview
Plain-Language Overview
Urinary Tract Infection (Klebsiella pneumoniae) is an infection that affects the urinary system, which includes the kidneys, bladder, and urethra. This condition occurs when the bacteria Klebsiella pneumoniae enter and multiply in the urinary tract, causing symptoms like painful urination, frequent urge to urinate, and lower abdominal discomfort. The infection can lead to inflammation and sometimes spread to the kidneys, causing more severe illness. It mainly affects the bladder but can involve other parts of the urinary tract. If untreated, it may cause complications such as kidney damage or bloodstream infection. The urinary system’s main function of removing waste and excess fluids from the body is disrupted during infection.
Clinical Definition
Urinary Tract Infection (Klebsiella pneumoniae) is a bacterial infection characterized by the colonization and invasion of the urinary tract by the gram-negative bacillus Klebsiella pneumoniae. This pathogen is a common cause of nosocomial and community-acquired UTIs, especially in patients with urinary catheters or structural abnormalities. The infection results from bacterial adherence to the uroepithelium, leading to inflammation, epithelial damage, and clinical symptoms such as dysuria, urgency, and suprapubic pain. It can involve the lower urinary tract (cystitis) or ascend to the upper tract causing pyelonephritis. The presence of a polysaccharide capsule in Klebsiella pneumoniae enhances its virulence by resisting phagocytosis. This infection is clinically significant due to its potential for antibiotic resistance and complications like sepsis.
Inciting Event
Introduction of bacteria into the urinary tract via ascending route from the perineum.
Urinary catheter placement providing a direct conduit for bacterial entry.
Urinary tract obstruction causing urine stasis and bacterial proliferation.
Recent antibiotic therapy disrupting normal flora and allowing overgrowth of resistant strains.
Latency Period
Hours to days from bacterial colonization to symptom onset in uncomplicated infections.
Longer latency in catheter-associated infections due to biofilm development.
Rapid symptom progression in patients with impaired immunity or obstruction.
Diagnostic Delay
Atypical presentation in elderly or immunocompromised patients leading to missed diagnosis.
Misattribution of symptoms to other causes such as vaginitis or prostatitis.
Delayed urine culture results causing postponement of targeted therapy.
Empiric treatment without culture leading to persistence of resistant organisms.
Clinical Presentation
Signs & Symptoms
Dysuria, urinary frequency, and urgency as hallmark lower urinary tract symptoms.
Suprapubic pain and discomfort during urination.
Fever and chills in upper urinary tract involvement or systemic infection.
Cloudy or foul-smelling urine due to bacterial infection.
Hematuria may be present in severe mucosal inflammation.
History of Present Illness
Dysuria, frequency, and urgency developing over hours to days.
Suprapubic pain and hematuria may be present in lower tract infection.
Fever and flank pain suggest progression to pyelonephritis.
Cloudy or foul-smelling urine indicating bacterial infection.
Symptoms often worsen rapidly in complicated or catheter-associated infections.
Past Medical History
Previous urinary tract infections increase risk of recurrence with resistant organisms.
History of urinary tract instrumentation such as catheterization or cystoscopy.
Diabetes mellitus impairing host defenses and glycosuria promoting bacterial growth.
Known urinary tract abnormalities including stones or strictures.
Recent hospitalization or antibiotic use selecting for multidrug-resistant strains.
Family History
No significant heritable predisposition to urinary tract infection with Klebsiella pneumoniae.
Rare familial syndromes causing urinary tract malformations may increase infection risk.
No direct association with genetic immune deficiencies specifically predisposing to this infection.
Physical Exam Findings
Suprapubic tenderness on palpation indicating bladder inflammation.
Costovertebral angle (CVA) tenderness suggesting pyelonephritis.
Fever and signs of systemic infection in severe cases.
Tachycardia and hypotension in complicated or septic UTI.
Diagnostic Workup
Diagnostic Criteria
Diagnosis is established by urinalysis showing pyuria and bacteriuria, and a urine culture confirming growth of Klebsiella pneumoniae at ≥10^5 colony-forming units/mL. Clinical symptoms such as dysuria, frequency, and urgency support the diagnosis. Imaging may be used if upper tract involvement or complications are suspected. Blood cultures may be indicated in severe cases to detect bacteremia.
Pathophysiology
Key Mechanisms
Colonization of the urinary tract by Klebsiella pneumoniae, a gram-negative encapsulated rod with a thick polysaccharide capsule that enhances virulence.
Adherence to uroepithelial cells via fimbriae facilitating bacterial persistence and invasion.
Biofilm formation on urinary catheters or damaged mucosa promoting chronic infection and antibiotic resistance.
Endotoxin release (lipopolysaccharide) triggering local inflammation and systemic symptoms.
Immune evasion through capsule-mediated resistance to phagocytosis and complement-mediated killing.
| Involvement | Details |
|---|---|
| Organs | Bladder is the main organ affected in lower urinary tract infection, presenting with symptoms like dysuria and urgency. |
Kidneys may be involved in upper urinary tract infection (pyelonephritis), leading to flank pain and systemic symptoms. | |
| Tissues | Uroepithelium is the specialized tissue lining the urinary tract that is the primary site of bacterial adherence and invasion in infection. |
| Cells | Neutrophils are the primary immune cells that infiltrate the urinary tract to phagocytose and kill Klebsiella pneumoniae. |
Urothelial cells line the urinary tract and act as a physical barrier and participate in immune signaling during infection. | |
| Chemical Mediators | Interleukin-8 (IL-8) is released by infected urothelial cells to recruit neutrophils to the site of infection. |
Tumor necrosis factor-alpha (TNF-α) promotes inflammation and helps coordinate the immune response against the bacteria. |
Treatments
Pharmacological Treatments
Third-generation cephalosporins (e.g., ceftriaxone)
- Mechanism:
Inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins
- Side effects:
Allergic reactions
Diarrhea
Elevated liver enzymes
- Clinical role:
First-line
Fluoroquinolones (e.g., ciprofloxacin)
- Mechanism:
Inhibit bacterial DNA gyrase and topoisomerase IV, preventing DNA replication
- Side effects:
Tendonitis
QT prolongation
Gastrointestinal upset
- Clinical role:
Second-line
Carbapenems (e.g., imipenem)
- Mechanism:
Broad-spectrum beta-lactam antibiotics that inhibit bacterial cell wall synthesis
- Side effects:
Seizures
Allergic reactions
Gastrointestinal upset
- Clinical role:
Rescue
Aminoglycosides (e.g., gentamicin)
- Mechanism:
Inhibit bacterial protein synthesis by binding to the 30S ribosomal subunit
- Side effects:
Nephrotoxicity
Ototoxicity
Neuromuscular blockade
- Clinical role:
Adjunctive
Non-pharmacological Treatments
Ensure adequate hydration to promote urinary flow and bacterial clearance.
Implement proper perineal hygiene to reduce bacterial colonization.
Use urinary catheterization only when necessary to minimize infection risk.
Prevention
Pharmacological Prevention
Low-dose prophylactic antibiotics such as nitrofurantoin in recurrent UTI cases.
Cranberry extract supplements may reduce bacterial adherence but evidence is limited.
Non-pharmacological Prevention
Adequate hydration to promote regular urine flow and bacterial clearance.
Proper perineal hygiene to reduce bacterial colonization near the urethra.
Avoidance of unnecessary catheterization to prevent nosocomial infections.
Prompt treatment of urinary obstruction to prevent stasis and infection.
Outcome & Complications
Complications
Pyelonephritis from ascending infection causing renal parenchymal inflammation.
Renal abscess formation due to localized infection.
Sepsis and septic shock from systemic spread of Klebsiella pneumoniae.
Emphysematous cystitis or pyelonephritis characterized by gas formation in tissues.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Urinary Tract Infection (Klebsiella pneumoniae) versus Urinary Tract Infection (Escherichia coli)
Urinary Tract Infection (Klebsiella pneumoniae) | Urinary Tract Infection (Escherichia coli) |
|---|---|
Klebsiella pneumoniae is a common cause of complicated or nosocomial UTI | Escherichia coli is the most common cause of community-acquired UTI |
Often associated with prior catheterization or hospitalization | Community-acquired infection without prior instrumentation |
Lactose-fermenting, indole-negative on culture | Lactose-fermenting, indole-positive on culture |
Urinary Tract Infection (Klebsiella pneumoniae) versus Urinary Tract Infection (Proteus mirabilis)
Urinary Tract Infection (Klebsiella pneumoniae) | Urinary Tract Infection (Proteus mirabilis) |
|---|---|
Klebsiella pneumoniae does not typically produce urease | Proteus mirabilis produces urease leading to alkaline urine |
No struvite stones typically associated | Struvite stones visible on imaging due to urease activity |
Non-motile colonies on culture | Swarming motility on culture plates |
Urinary Tract Infection (Klebsiella pneumoniae) versus Acute Pyelonephritis
Urinary Tract Infection (Klebsiella pneumoniae) | Acute Pyelonephritis |
|---|---|
Lower urinary tract symptoms without systemic signs | Fever, flank pain, and systemic symptoms predominate |
Imaging typically normal or shows bladder involvement only | Renal ultrasound or CT shows renal enlargement or abscess |
Pyuria without white blood cell casts | Pyuria with white blood cell casts in urine |
Urinary Tract Infection (Klebsiella pneumoniae) versus Cystitis caused by Enterococcus faecalis
Urinary Tract Infection (Klebsiella pneumoniae) | Cystitis caused by Enterococcus faecalis |
|---|---|
Gram-negative bacilli, often sensitive to cephalosporins | Gram-positive cocci in chains, often resistant to cephalosporins |
Often community-acquired or associated with catheter use | Common in patients with recent antibiotic use or urinary instrumentation |
Often treated successfully with cephalosporins or fluoroquinolones | Requires ampicillin or vancomycin due to resistance |
Urinary Tract Infection (Klebsiella pneumoniae) versus Fungal Urinary Tract Infection (Candida species)
Urinary Tract Infection (Klebsiella pneumoniae) | Fungal Urinary Tract Infection (Candida species) |
|---|---|
Gram-negative rods seen on urine microscopy | Yeast cells or pseudohyphae seen on urine microscopy |
Occurs in broader population including healthy individuals | Common in immunocompromised or diabetic patients with indwelling catheters |
Treated with antibiotics targeting gram-negative bacteria | Requires antifungal therapy such as fluconazole |